Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis

IMPORTANCE: A widely cited meta-analysis of randomized clinical trials has claimed ivermectin as an effective treatment for prevention of mortality in COVID-19. However, an unrecognized interaction variable with the relative risk (RR) of mortality may substantially change the appropriate interpretat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitterman, Avi, Martins, Caitlin Pestana, Cices, Ahuva, Nadendla, Makarand Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938718/
https://www.ncbi.nlm.nih.gov/pubmed/35311963
http://dx.doi.org/10.1001/jamanetworkopen.2022.3079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938718/
https://www.ncbi.nlm.nih.gov/pubmed/35311963
http://dx.doi.org/10.1001/jamanetworkopen.2022.3079

Ejemplares similares